Brind.
  1. The FDA and the Securities and Exchange Commission entered into a Memorandum of Understanding (MOU) to enhance cooperation between the two agencies.

The SEC and FDA formalized interagency cooperation, with the SEC reviewing company filings regarding FDA interactions and market impacts.

1 report, 1 independent Updated Sep 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The SEC and FDA formalized interagency cooperation, with the SEC reviewing company filings regarding FDA interactions and market impacts.

Who's involved

What this event is mainly about
SEC

Keep exploring

Part of

The FDA and the Securities and Exchange Commission entered into a Memorandum of Understanding (MOU) to enhance cooperation between the two agencies. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped